Patent US2267162A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4100267A Expired / Lapsed US ⏱️ 0.0 years remaining

Method of detecting hepatitis B core antigen and antibody

Assignee: Ortho Clinical Diagnostics Inc
•
Filing: 1975-10-01
•
Granted: 1978-07-11
•
Expires: 1995-10-01
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The formation of antibodies to the A-2 plaque virus previously propagated in tissue culture is described. The application describes an immune response against those antibodies and against the A-2 plaque virus antigen which is associated with human viral hepatitis both of type A and B origin. The reaction of antibody for A-2 plaque virus with the antigen from stool specimens of volunteers infected with type A hepatitis and from the sera of patients diagnosed as having type B hepatitis is described. Convalescent sera from both type A and type B hepatitis patients in reaction with the virus, demonstrate the presence of antigenic components in the plaque virus which react with human antibody formed in response to infection with either type A or type B hepatitis. Moreover, the A-2 plaque antibodies react with hepatitis B core antigen, while antibodies to HB c Ag react with A-2 plaque antigen. Additionally, methods for inducing antibody formation in humans from the A-2 plaque virus antigen are described, as are methods for detecting HB c Ag, HB c Ab, HAAg and HAAb.

Inventors

  • 👤 Eugene Douglas Shaw

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-01 09:19
CPC Classifications
C; C07; C07K; C07K14/00; C07K14/005; A; A61; A61K; A61K39/00; A61K39/12; A61K39/29; G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/576; C12; C12N; C12N2730/00; C12N2730/00011; C12N2730/10011; C12N2730/10111; C12N2730/10122; C12N2730/10134; C12N2770/00; C12N2770/00011; C12N2770/32011; C12N2770/32411; C12N2770/32422; C12N2770/32434; Y; Y02; Y02A; Y02A50/00; Y02A50/30; Y10; Y10S; Y10S436/00; Y10S436/82

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 50 words
The method for detecting hepatitis B core antigen in a material suspected of containing said antigen which comprises contacting said material in a system with antibodies to A-2 plaque virus thereby to cause said antigen if present to cross-react with said antibodies, and then determining whether said cross-reaction has occurred.
Claim 2
Independent Claim 50 words
The method for detecting hepatitis B core antigen in a material suspected of containing said antigen which comprises contacting said material in a system with antibodies to A-2 plaque virus thereby to cause said antigen if present to cross-react with said antibodies, and then determining whether said cross-reaction has occurred.
Claim 3
Dependent Claim 21 words
The method according to claim 1 wherein the antibodies are antibodies to A-2 plaque virus corresponding to ATCC No. VR 812.
Claim 4
Dependent Claim 16 words
The method of claim 2 wherein sad system is an immuno-counterelectrophoresis, radioimmunoassay or immunoelectron microscopic system.
Claim 5
Independent Claim 49 words
The method for detecting hepatitis B core antibody in a material suspected of containing said antibody which comprises contacting said material in a system with A-2 plaque virus antigen thereby to cause said antibody if present to cross-react with said antigen, and then determining whether said reaction has occurred.
Claim 6
Independent Claim 49 words
The method for detecting hepatitis B core antibody in a material suspected of containing said antibody which comprises contacting said material in a system with A-2 plaque virus antigen thereby to cause said antibody if present to cross-react with said antigen, and then determining whether said reaction has occurred.
Claim 7
Dependent Claim 18 words
The method according to claim 4 wherein the A-2 plaque virus antigen corresponds to ATCC No. VR 812.
Claim 8
Dependent Claim 16 words
The method of claim 5 wherein said system is an immuno-counterelectrophoretic, radioimmunoassay or immunoelectron microscopic system.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1981-07-10 1982-01-09 1982-07-11 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1985-07-10 1986-01-09 1986-07-11 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1989-07-10 1990-01-09 1990-07-11 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag